LAO; Yuanzhi

Patent Applications and Registrations

Patent applications and USPTO patent grants for LAO; Yuanzhi.The latest application filed is for "usage of oblongifolin c, a natural compound from garcinia yunnanensis hu, on treating cancer as metastasis inhibitor and autophagic flux inhibitor".

Company Profile

0.2.9

LAO; Yuanzhi - Shanghai CN
Lao; Yuanzhi - Hong Kong HK
LAO; Yuanzhi - HK HK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Usage Of Oblongifolin C, A Natural Compound From Garcinia Yunnanensis Hu, On Treating Cancer As Metastasis Inhibitor And Autophagic Flux Inhibitor App 20170035824 - XU; Hongxi ; et al.	2017-02-09
Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer Grant 9,408,811 - Xu , et al. August 9, 2	2016-08-09
Anti-cervical cancer compound and method of use thereof Grant 9,339,488 - Xu , et al. May 17, 2	2016-05-17
Usage Of Guttiferone K For Treating High Metastatic Cancer App 20150231090 - XU; Hongxi ; et al.	2015-08-20
Anti-cervical Cancer Compound and Method of Use Thereof App 20150038569 - XU; Hongxi ; et al.	2015-02-05
Anti-prostate Cancer Compound And Method Of Use Thereof App 20150025155 - XU; Hongxi ; et al.	2015-01-22
Usage Of Guttiferone K, A Natural Compound From Garcinia Yunnanensis Hu On Treating High Metastatic Esophageal Cancer App 20150011646 - XU; Hongxi ; et al.	2015-01-08
Usage Of Oblongifolin C, A Natural Compound From Garcinia Yunnanensis Hu, On Treating Cancer As Metastasis Inhibitor And Autophagic Flux Inhibitor App 20140194530 - Xu; Hongxi ; et al.	2014-07-10
Polyprenylated Benzoylphloroglucinols With Anticancer Activity App 20140194499 - XU; Hongxi ; et al.	2014-07-10
Usage Of Sodium Houttuyfonate On Inhibiting Idiopathic Pulmonary Fibrosis And Bleomycin Induced Pulmonary Fibrosis App 20140194528 - XU; Hongxi ; et al.	2014-07-10
Compounds, Methods Of Preparation And Use Thereof For Treating Cancer App 20130210906 - XU; Hongxi ; et al.	2013-08-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.